<DOC>
	<DOCNO>NCT02852187</DOCNO>
	<brief_summary>Prospective randomize clinical study compare Signus MOBIS PEEK v SIGNUS MOBIS II ST patient Degenerative Disc Disease one two contiguous level L2-S1</brief_summary>
	<brief_title>Single Center Study Comparing MOBIS II ST v MOBIS PEEK</brief_title>
	<detailed_description>The protocol include skeletally mature patient male female , 18 89 year old , degenerative disc disease ( DDD ) one two contiguous level L2-S1 . DDD define discogenic back pain degeneration disc confirm patient history radiographic study . Patients may also Grade I spondylolisthesis retrolisthesis involve level ( ) . Patient complete least six ( 6 ) month non-operative treatment . Patients may previous non-fusion surgery involve spinal level ( ) follow clinically two year .</detailed_description>
	<criteria>1 . The patient symptomatic degenerative disc disease ( DDD ) one two contiguous level L2S1 . 2 . The patient document conservative ( nonoperative ) treatment least 6 month . 3 . The patient VAS back pain ≥ 60 mm . 4 . The patient ODI ≥ 40 % . 5 . The patient least 18 year age skeletally mature . 6 . The general condition patient appropriate surgery , evaluate Investigator . 7 . The patient willing able comply study requirement . 8 . The patient agree participate study . 1 . The patient undergone prior spinal fusion surgery propose treatment level ( ) . 2 . The patient osteoporosis severe osteopenia determine Investigator . A clinical SCORE calculator may utilize female 40 year age . 3 . The patient grade 2 high spondylolisthesis retrolisthesis affect level ( ) . 4 . The patient diffuse multilevel neoplastic disease adjacent normal segment exist engagement instrumentation . 5 . The patient active infection . 6 . The patient pregnant plan become pregnant next two year . 7 . The patient mentally ill history drug abuse severe depression/ psychosocial issue . 8 . The patient know allergy polyether ether ketone ( PEEK ) , stainless steel tantalum/titanium . 9 . The patient currently enrol investigational spine study . 10 . The patient rheumatoid arthritis , ankylose spondylitis autoimmune disease . 11 . The patient symptomatic fibrous arachnoiditis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Intervertebral Disc Degeneration</keyword>
	<keyword>Lumbar Spinal Disease</keyword>
</DOC>